GMEDNYSESEC EDGAREDGAR

GLOBUS MEDICAL INC

Surgical & Medical Instruments & Apparatus·AUDUBON, PA·FY end 12/31·CIK 1237831

Board of Directors

10 members · 8 independent · FY 2025
DirectorRoleTenureAgeCommitteesIndep.Annual fees
David C. PaulChair23y59CompNCG——
Keith W. PfeilCEO and Director1y47NCG——
David D. DavidarDirector23y60CompNCG—
Daniel T. LemaitreDirector15y72CompAudit—
Ann D. RhoadsDirector15y60AuditNCG—
James R. TobinLead Independent Director11y81NCGComp—
Stephen T. ZarrilliDirector7y64Audit—
Robert A. DouglasDirector7y66Audit—
Leslie V. NorwalkDirector3y60Audit—
Daniel J. WoltermanDirector3y69Comp—

Risk-factor diff

FY 2025 10-K vs. FY 2024
+90 new−113 removed

Net-new paragraphs in the most recent 10-K's Item 1A. Companies rarely add risk language without a real reason — additions here are often a leading signal of management concerns.

NEW · FY 2025

“Our sales and operating results may be negatively affected, and we may not grow if we are unable to compete successfully.”

NEW · FY 2025

“The proliferation of physician-owned distributorships (“PODs”) could result in increased pricing pressure on our products or harm our ability to sell our products to physicians.”

NEW · FY 2025

“There may be future changes in legal and regulatory requirements, and changes impacting the federal workforce and agency policies may impact our operations and product development.”

NEW · FY 2025

“Our future capital needs are uncertain, and we may need to raise funds in the future, and such funds may not be available on acceptable terms or at all.”

NEW · FY 2025

“Because of their significant stock ownership, our executive officers, and our directors and principal stockholders will be able to exert control over us and our significant corporate decisions.”

+ 25 more new paragraphs not shown

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.